InSilico Medicine Jun 18 2026 Insilico Medicine will attend the BIO 2026 International Convention, held from June 22 to 25 at the San Diego Convention Center. Led by Dr. Alex Zhavoronkov, Founder, CEO, and CBO of Insilico Medicine, the Insilico Medicine team will meet with biopharma partners, investors, and researchers at Booth #4021 to explore collaboration opportunities. Insilico Medicine will showcase the core capabilities of its end-to-end Pharma.AI platform as well as its latest R&D